Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 7 (2010), Issue 3 (March)

1. Arterial wall dosimetry for non-Hodgkin lymphoma patients treated with radioimmunotherapy.
   J Nucl Med, 51(3): 368-75. [Abstract] [Full-text]
2. Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic model.
   J Nucl Med, 51(3): 484-91. [Abstract] [Full-text]
3. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
   J Clin Invest, 120(3): 694-705. [Abstract] [Full-text]
4. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
   Lancet, 375(9717): 816-23. [Abstract] [Full-text]
5. Accumulation of DNA double-strand breaks in normal tissues after fractionated irradiation.
   Int J Radiat Oncol Biol Phys, 76(4): 1206-13. [Abstract] [Full-text]
6. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.
   Int J Radiat Oncol Biol Phys, 76(4): 963-72. [Abstract] [Full-text]
7. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer.
   Int J Radiat Oncol Biol Phys, 76(4): 1054-60. [Abstract] [Full-text]
8. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy.
   Int J Radiat Oncol Biol Phys, 76(4): 1251-8. [Abstract] [Full-text]
9. Dynamic jaws and dynamic couch in helical tomotherapy.
   Int J Radiat Oncol Biol Phys, 76(4): 1266-73. [Abstract] [Full-text]
10. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.
    Int J Radiat Oncol Biol Phys, 76(4): 1185-92. [Abstract] [Full-text]
11. A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible.
    Int J Radiat Oncol Biol Phys, 76(4): 1066-72. [Abstract] [Full-text]
12. Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes.
    Int J Radiat Oncol Biol Phys, 76(4): 1026-36. [Abstract] [Full-text]
13. Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer.
    Int J Radiat Oncol Biol Phys, 76(4): 1085-91. [Abstract] [Full-text]
14. Early expansion of the intracranial CSF volume after palliative whole-brain radiotherapy: results of a longitudinal CT segmentation analysis.
    Int J Radiat Oncol Biol Phys, 76(4): 1171-6. [Abstract] [Full-text]
15. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.
    Int J Radiat Oncol Biol Phys, 76(4): 1177-84. [Abstract] [Full-text]
16. Whole-pelvis radiotherapy in combination with interstitial brachytherapy: does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer?
    Int J Radiat Oncol Biol Phys, 76(4): 1078-84. [Abstract] [Full-text]
17. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.
    Int J Radiat Oncol Biol Phys, 76(4): 1114-20. [Abstract] [Full-text]
18. Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable.
    Int J Radiat Oncol Biol Phys, 76(4): 1061-5. [Abstract] [Full-text]
19. Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization.
    Int J Radiat Oncol Biol Phys, 76(4): 1037-44. [Abstract] [Full-text]
20. Outcome after conservative surgery and breast irradiation in 5,717 patients with breast cancer: implications for supraclavicular nodal irradiation.
    Int J Radiat Oncol Biol Phys, 76(4): 978-83. [Abstract] [Full-text]
21. Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen.
    Int J Radiat Oncol Biol Phys, 76(4): 1193-8. [Abstract] [Full-text]
22. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Int J Radiat Oncol Biol Phys, 76(4): 991-7. [Abstract] [Full-text]
23. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.
    J Clin Oncol, 28(8): 1380-6. [Abstract] [Full-text]
24. Feasibility of using internal radiation-generating devices in radiotherapy.
    Health Phys, 98(4): 614-20. [Abstract] [Full-text]
25. Approach to radiation therapy in hepatocellular carcinoma.
    Cancer Treat Rev, 36(2): 157-63. [Abstract] [Full-text]
26. Comparative study of Curiementor ionization chambers using Monte Carlo simulations.
    Appl Radiat Isot, 68(6): 1121-7. [Abstract] [Full-text]
27. Biodistribution of a radiolabelled thermoresponsive polymer in mice.
    Appl Radiat Isot, 68(6): 1073-8. [Abstract] [Full-text]
28. Calibration coefficient of reference brachytherapy ionization chamber using analytical and Monte Carlo methods.
    Appl Radiat Isot, 68(6): 1108-15. [Abstract] [Full-text]
29. Stereotactic body radiation therapy for inoperable early stage lung cancer.
    JAMA, 303(11): 1070-6. [Abstract] [Full-text]
30. Irradiation and IL-15 promote loss of CD8 T-cell tolerance in response to lymphopenia.
    Blood, 115(11): 2196-202. [Abstract] [Full-text]
31. Extrusion of embolization coils through the carotid artery in a radiated neck.
    Auris Nasus Larynx, 37(3): 390-3. [Abstract] [Full-text]
32. Bax, cytochrome c, and caspase-8 staining in parotid cancer patients: markers of susceptibility in radiotherapy?
    Otolaryngol Head Neck Surg, 142(4): 605-11. [Abstract] [Full-text]
33. Stereotactic radiotherapy for stage I lung cancer: current results and new developments.
    Cancer Radiother, 14(2): 115-8. [Abstract] [Full-text]
34. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation.
    Exp Hematol, 38(4): 270-81. [Abstract] [Full-text]
35. Early alterations in cytokine expression in adult compared to developing lung in mice after radiation exposure.
    Radiat Res, 173(4): 522-35. [Abstract] [Full-text]
36. Gene expression profiling distinguishes radiation-induced fibrosing alveolitis from alveolitis in mice.
    Radiat Res, 173(4): 512-21. [Abstract] [Full-text]
37. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes.
    Radiat Res, 173(4): 505-11. [Abstract] [Full-text]
38. Short-term effects of whole-body exposure to (56)fe ions in combination with musculoskeletal disuse on bone cells.
    Radiat Res, 173(4): 494-504. [Abstract] [Full-text]
39. Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality.
    Radiat Res, 173(4): 462-8. [Abstract] [Full-text]
40. A metalloporphyrin antioxidant alters cytokine responses after irradiation in a prostate tumor model.
    Radiat Res, 173(4): 441-52. [Abstract] [Full-text]
41. Comparing radiation treatments using intensity-modulated beams, multiple arcs, and single arcs.
    Int J Radiat Oncol Biol Phys, 76(5): 1554-62. [Abstract] [Full-text]
42. Permanent prostate brachytherapy in prostate glands <20 cm(3).
    Int J Radiat Oncol Biol Phys, 76(5): 1450-5. [Abstract] [Full-text]
43. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.
    Int J Radiat Oncol Biol Phys, 76(5): 1360-8. [Abstract] [Full-text]
44. Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a Phase I study.
    Int J Radiat Oncol Biol Phys, 76(5): 1390-5. [Abstract] [Full-text]
45. Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.
    Int J Radiat Oncol Biol Phys, 76(5): 1382-9. [Abstract] [Full-text]
46. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy.
    Int J Radiat Oncol Biol Phys, 76(5): 1480-5. [Abstract] [Full-text]
47. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity.
    Int J Radiat Oncol Biol Phys, 76(5): 1369-75. [Abstract] [Full-text]
48. Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival.
    Int J Radiat Oncol Biol Phys, 76(5): 1486-92. [Abstract] [Full-text]
49. Seed implant retention score predicts the risk of prolonged urinary retention after prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 76(5): 1445-9. [Abstract] [Full-text]
50. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 76(5): 1433-8. [Abstract] [Full-text]
51. Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study.
    Int J Radiat Oncol Biol Phys, 76(5): 1353-9. [Abstract] [Full-text]
52. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure.
    Int J Radiat Oncol Biol Phys, 76(5): 1339-46. [Abstract] [Full-text]
53. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Int J Radiat Oncol Biol Phys, 76(5): 1456-62. [Abstract] [Full-text]
54. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).
    Int J Radiat Oncol Biol Phys, 76(5): 1333-8. [Abstract] [Full-text]
55. Clinical evaluation of stereotactic target localization using 3-Tesla MRI for radiosurgery planning.
    Int J Radiat Oncol Biol Phys, 76(5): 1472-9. [Abstract] [Full-text]
56. Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma.
    Am J Ophthalmol, 149(4): 608-15. [Abstract] [Full-text]
57. Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    J Nucl Med, 51(4): 624-31. [Abstract] [Full-text]
58. Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma.
    Am J Surg Pathol, 34(4): 562-8. [Abstract] [Full-text]
59. Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients.
    Am J Hematol, 85(4): 243-8. [Abstract] [Full-text]
60. (99m)Tc Auger electrons for targeted tumour therapy: a review.
    Int J Radiat Biol, 86(4): 261-70. [Abstract] [Full-text]

© 2004-2012 Radiotherapy Research Today. All Rights Reserved.